Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics is a research paper published in Trends in Pharmacological Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 217 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R21 AI144716
NIDDK NIH HHS
Grant: R01 DK113599
National Institutes of Health
Grant: AI144716
NIAID NIH HHS
Grant: R56 AI064285
National Institutes of Health
Grant: AI064285
Crohn's and Colitis Foundation
Grant: 654758
NIAID NIH HHS
Grant: R01 AI064285
National Institutes of Health
Grant: DK113599
National Institutes of Health
Grant: 1R21AI144716-01A1
Designer probiotics for prevention of cholera
National Institutes of Health
Grant: 5R01DK113599-02
Designer Probiotics for the treatment of intestinal infection and inflammation
FWCI
20.24
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals